Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. - Wikidata - wikimedia - TriplyDB

Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha.

Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha.

http://www.wikidata.org/entity/Q35081587

about

A feedback regulatory loop between HIF-1α and miR-21 in response to hypoxia in cardiomyocytes Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth Hypoxic signaling during tissue repair and regenerative medicine Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration HIF-1alpha is essential for myeloid cell-mediated inflammation Engineering vascularized tissues using natural and synthetic small molecules Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence.The ubiquitin system, disease, and drug discovery.Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction Impaired angiogenesis and mobilization of circulating angiogenic cells in HIF-1alpha heterozygous-null mice after burn wounding.Conditional HIF-1alpha expression produces a reversible cardiomyopathy.HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation.Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1)Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis Physiology meets biophysics: visualizing the interaction of hypoxia-inducible factor 1 alpha with p300 and CBP Proteomic dissection of the von Hippel-Lindau (VHL) interactome.Control of the hypoxic response in Drosophila melanogaster by the basic helix-loop-helix PAS protein similar.Directed glia-assisted angiogenesis in a mature neurosensory structure: pericytes mediate an adaptive response in human dental pulp that maintains blood-barrier function.Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.Lung cancer therapeutics that target signaling pathways: an update.From antiangiogenesis to hypoxia: current research and future directions.Vascular permeability, vascular hyperpermeability and angiogenesis von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.HIF hydroxylation and the mammalian oxygen-sensing pathway Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein.HIF and oxygen sensing; as important to life as the air we breathe?VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.Enhanced renoprotective effect of HIF-1α modified human adipose-derived stem cells on cisplatin-induced acute kidney injury in vivo.The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1.

P2860

Q24300231-902B70B6-8C75-45C0-8B79-F3D42F55AF44 Q24536055-49516E83-6AFD-4901-B917-2B527724D194 Q24613344-978F8889-354D-4973-B531-546D5E4BDAE2 Q24800550-9D1852B3-F707-4D00-ABEC-B2B82D9F2080 Q26824402-3EED6492-DF05-46FB-9295-A671165E28A3 Q26849304-10130DA6-F01F-49D9-B349-9191BD1D6723 Q28509277-3040F022-582B-4721-98CC-BA7EAE524718 Q28591474-7AF08EB5-78EB-4819-A4B5-A7C3B773F04C Q29617581-E451CB8A-1CAA-4CD4-A098-9EB5B218717E Q30439954-B0C8A022-D774-41E9-9BDF-02E101D4F1B4 Q30468545-33915976-1CD4-408D-89CB-0A95EE163F70 Q33384295-EA487AD7-557A-457E-B476-1A01B1951BEA Q33392329-8CC3D85F-7DBC-4434-9CC2-AD45F6EDABF1 Q33531908-048E3B5C-C898-4E14-99AD-90C0E36589E3 Q33640248-2455686D-3E2C-4026-B508-036F89B4661C Q33705004-A1A670F8-A7C9-4B8E-B7DA-14CCD4D37C37 Q33752054-3B474BD3-ACE5-4775-B03B-B177B4AEE00A Q33900675-666D0F0F-AB38-4D8F-A0B1-B235CC790946 Q33983876-6C40C5E5-8AF6-4A96-8A2D-17F3594DFD94 Q34009713-905444D9-2418-4E0C-A6B7-74E8A0313EBB Q34074553-7ED13353-8411-42D2-B060-5A14C9CE810F Q34109970-0B1258E8-6C80-4C82-831E-A4253DE42E3C Q34153706-F2F20E10-301E-47EE-859D-7432B8137393 Q34218966-65F395CB-313F-485E-8894-3D6CAB02A5A8 Q34285871-FF90B011-003D-4D8D-802D-3647C30AF2A7 Q34296890-9C6DB3F2-FFA4-4ACD-9B91-41F1DE050336 Q34479397-F7A3F27A-4B51-4B57-B582-73ABF11256A6 Q34541960-246B617B-D312-486E-B7D4-844073F92946 Q34621100-DBD2C81A-73E5-4A86-A2D0-E23EE5A30E50 Q34753662-A4353F78-3CD1-4442-A94A-38BEBB13AA21 Q34784862-A8AE5901-59A0-4B51-B1B8-D82CF41B9582 Q35065823-AA534F65-D500-4436-AADA-223A4463228C Q35083718-B97FEB72-1D2A-4321-9AF7-EB99D54C760C Q35086143-7563E2A4-1DE8-4D02-954C-21B9D5407202 Q35087893-B85282B3-034E-42CF-8891-BE793A5D1D77 Q35160986-F4F0CEF9-C474-420E-9A88-AAD034729D4C Q35164593-26933744-D1A5-4DC7-B271-69DCA1CD4BC2 Q35554334-5C8D90C0-3365-4DF4-A66D-E2E7C6D0A32A Q35686195-05AA57D4-7478-4585-8BB6-3DCA6BBF1CD0 Q35742606-4D58957F-E10E-4E1F-977D-4E46DDDB97E8

P2860

Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha.

http://www.wikidata.org/entity/Q35081587

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Induction of hypervascularity ...... poxia-inducible factor-1alpha.

@ast

Induction of hypervascularity ...... poxia-inducible factor-1alpha.

@en

type

label

Induction of hypervascularity ...... poxia-inducible factor-1alpha.

@ast

Induction of hypervascularity ...... poxia-inducible factor-1alpha.

@en

prefLabel

Induction of hypervascularity ...... poxia-inducible factor-1alpha.

@ast

Induction of hypervascularity ...... poxia-inducible factor-1alpha.

@en

P1433

Q35081587-4A8677B7-52D2-4E97-9D69-127395E54292

P1476

Q35081587-2ABCF06C-02E7-449A-AF48-FA5E73359FB3

P2093

Q35081587-28638388-4C07-4CD5-B415-0E65653A6644

Q35081587-49D08801-3F99-4B6D-BDC0-51ADE4A82AD7

Q35081587-5379A27E-6274-42E1-9FC3-F8C5275397B4

Q35081587-972F7A77-6A15-4CF3-84D3-B0EDFCCDB654

Q35081587-ABF78587-4E1C-415B-809D-3EF28FE7563A

Q35081587-E15AB1C1-6068-43D5-B693-4E6812A0844A

Q35081587-F25D0411-E3C2-4CA4-A83D-5D4D155E9D16

P2860

Q35081587-0269598F-9C93-4E39-A2AA-765CFE1206D8

Q35081587-069730B8-B34F-4032-9498-4A1C0F56D014

Q35081587-1D89A6BB-A472-4CD7-B1A6-7A8A191DDFBF

Q35081587-2DE2254D-1482-4729-9B45-1EE352FA4EC2

Q35081587-2E2807B1-0A0A-4C60-86E4-373A0EBFD624

Q35081587-2E5CF432-29D6-44C1-AE3F-2E04159C757D

Q35081587-2E762FD6-FC7B-412F-9EB2-5A98EE870AF4

Q35081587-30A8ABEA-F3EC-47B1-80B6-52009A4F95FC

Q35081587-34DDCBBD-9789-413C-8E2B-338ED66758CF

Q35081587-38031E2F-43D2-4BF8-B481-49A5C0D8D107

P304

Q35081587-7EA7543B-163A-494C-8A4D-155EB0264A51

P31

Q35081587-CEC5A10D-D6B1-41A9-A2D6-4B5C15CE0CD5

P356

Q35081587-E91E48F2-4979-4EBC-AEE2-87F7DD73BDE4

P433

Q35081587-66DF3726-56E4-4598-B4A2-DAAF88B89420

P478

Q35081587-52CCA6E9-B6F9-4193-83CE-0C2B8D1FD6E6

P577

Q35081587-9088A3D7-B42F-4FDA-863D-4618A51570D6

P5875

Q35081587-182A3ADB-CD74-46E2-9DE8-E87B2387D0E7

P698

Q35081587-2CB2DB7A-EA25-48C2-AC95-F35BD054F04B

P921

Q35081587-0CC537B2-C4B0-4AFC-8D86-6D554E816978

Q35081587-129E8983-FA3F-42D6-83FB-F30E26B0EEA5

Q35081587-C74DB9AD-18B1-4CA3-8194-297B5AEB4C29

P932

Q35081587-66B934FD-8A71-4F63-AB57-CB727855DC6C

P356

P1433

Genes & Development

P1476

Induction of hypervascularity ...... poxia-inducible factor-1alpha.

@en

P2093

D A Elson

http://www.w3.org/2001/XMLSchema#string

D G Ginzinger

http://www.w3.org/2001/XMLSchema#string

D M McDonald

http://www.w3.org/2001/XMLSchema#string

G Thurston

http://www.w3.org/2001/XMLSchema#string

J M Arbeit

http://www.w3.org/2001/XMLSchema#string

L E Huang

http://www.w3.org/2001/XMLSchema#string

R S Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

Openings between defective endothelial cells explain tumor vessel leakiness

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

Angiogenesis in cancer and other diseases

Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

P304

2520-2532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GAD.914801

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11767777

http://www.w3.org/2001/XMLSchema#string

P698

11581158

http://www.w3.org/2001/XMLSchema#string

P921

P932

312791

http://www.w3.org/2001/XMLSchema#string